Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Leukemia

Free Subscription Articles published in Oncogene Retrieve available abstracts of 25 articles: HTML format

Single Articles

November 2022
1. MA D, Liu P, Hu C, Zhou Z, et al
   Intracellular angiopoietin-1 promotes TKI-resistance via activation of JAK/STAT5 pathway in chronic myeloid leukemia.
   Oncogene. 2022 Nov 17. pii: 10.1038/s41388-022-02536.
   PubMed     Abstract available
   
   
   
2. BURKE A, Borot F, Du X, Churchill M, et al
   A novel therapeutic bispecific format based on synthetic orthogonal heterodimers enables T cell activity against Acute myeloid leukemia.
   Oncogene. 2022 Nov 10. pii: 10.1038/s41388-022-02532.
   PubMed     Abstract available
   
   
   
3. LEE LM, Christodoulou EG, Shyamsunder P, Chen BJ, et al
   A novel network pharmacology approach for leukaemia differentiation therapy using Mogrify((R)).
   Oncogene. 2022;41:5160-5175.
   PubMed     Abstract available
   
   
   October 2022
4. KANG S, Wang L, Xu L, Wang R, et al
   Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype.
   Oncogene. 2022;41:4696-4708.
   PubMed     Abstract available
   
   
   September 2022
5. MAIQUES-DIAZ A, Nicosia L, Basma NJ, Romero-Camarero I, et al
   HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block.
   Oncogene. 2022 Sep 28. pii: 10.1038/s41388-022-02471.
   PubMed     Abstract available
   
   
   May 2022
6. GARZON R, Pichiorri F, Palumbo T, Visentini M, et al
   Correction to: MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia.
   Oncogene. 2022 May 11. pii: 10.1038/s41388-022-02351.
   PubMed    
   
   
   March 2022
7. WANG H, Zhang D, Cui X, Dai Y, et al
   Loss of IRF7 accelerates acute myeloid leukemia progression and induces VCAM1-VLA-4 mediated intracerebral invasion.
   Oncogene. 2022 Mar 7. pii: 10.1038/s41388-022-02233.
   PubMed     Abstract available
   
   
   
8. CHEN TC, Yao CY, Chen YR, Yuan CT, et al
   Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair.
   Oncogene. 2022;41:1576-1588.
   PubMed     Abstract available
   
   
   January 2022
9. FIDYT K, Pastorczak A, Cyran J, Crump NT, et al
   Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.
   Oncogene. 2022 Jan 28. pii: 10.1038/s41388-022-02196.
   PubMed     Abstract available
   
   
   
10. MADRAZO E, Gonzalez-Novo R, Ortiz-Placin C, Garcia de Lacoba M, et al
    Fast H3K9 methylation promoted by CXCL12 contributes to nuclear changes and invasiveness of T-acute lymphoblastic leukemia cells.
    Oncogene. 2022 Jan 8. pii: 10.1038/s41388-021-02168.
    PubMed     Abstract available
    
    
    December 2021
11. PAGE EC, Heatley SL, Eadie LN, McClure BJ, et al
    HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort.
    Oncogene. 2021 Dec 2. pii: 10.1038/s41388-021-02126.
    PubMed     Abstract available
    
    
    October 2021
12. ZHANG J, Zhai J, Wong CC, Chen H, et al
    A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Oncogene. 2021 Oct 8. pii: 10.1038/s41388-021-01941.
    PubMed     Abstract available
    
    
    September 2021
13. HELTEMES-HARRIS LM, Hubbard GK, LaRue RS, Munro SA, et al
    Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
    Oncogene. 2021 Sep 17. pii: 10.1038/s41388-021-02012.
    PubMed     Abstract available
    
    
    
14. WILHELM A, Marschalek R
    The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(4;11).
    Oncogene. 2021 Sep 6. pii: 10.1038/s41388-021-02001.
    PubMed     Abstract available
    
    
    
15. REJESKI K, Duque-Afonso J, Lubbert M
    AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms.
    Oncogene. 2021;40:5665-5676.
    PubMed     Abstract available
    
    
    August 2021
16. KUNDU A, Kowarz E, Marschalek R
    The role of reciprocal fusions in MLL-r acute leukemia: studying the chromosomal translocation t(6;11).
    Oncogene. 2021 Aug 5. pii: 10.1038/s41388-021-01983.
    PubMed     Abstract available
    
    
    
17. SCHWALBE EC, H L, Lafta F, Barrow TM, et al
    Integration of genome-level data to allow identification of subtype-specific vulnerability genes as novel therapeutic targets.
    Oncogene. 2021;40:5213-5223.
    PubMed     Abstract available
    
    
    July 2021
18. KARUNANITHI S, Liu R, Hou Y, Gonzalez G, et al
    Thioredoxin reductase is a major regulator of metabolism in leukemia cells.
    Oncogene. 2021 Jul 8. pii: 10.1038/s41388-021-01924.
    PubMed     Abstract available
    
    
    June 2021
19. CHEN Z, Shao YL, Wang LL, Lin J, et al
    YTHDF2 is a potential target of AML1/ETO-HIF1alpha loop-mediated cell proliferation in t(8;21) AML.
    Oncogene. 2021;40:3786-3798.
    PubMed     Abstract available
    
    
    May 2021
20. YUSENKO MV, Trentmann A, Casolari DA, Abdel Ghani L, et al
    C/EBPbeta is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Oncogene. 2021 May 6. pii: 10.1038/s41388-021-01800.
    PubMed     Abstract available
    
    
    April 2021
21. ZHOU M, Zhang X, Liu C, Nie D, et al
    Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6.
    Oncogene. 2021 Apr 30. pii: 10.1038/s41388-021-01799.
    PubMed     Abstract available
    
    
    
22. WEI Y, Lu W, Yu Y, Zhai Y, et al
    miR-29c&b2 encourage extramedullary infiltration resulting in the poor prognosis of acute myeloid leukemia.
    Oncogene. 2021 Apr 22. pii: 10.1038/s41388-021-01775.
    PubMed     Abstract available
    
    
    
23. HAO T, Zhang C, Wang Z, Buck A, et al
    An aging mouse model of human chronic myeloid leukemia.
    Oncogene. 2021 Apr 6. pii: 10.1038/s41388-021-01770.
    PubMed     Abstract available
    
    
    January 2021
24. BAI J, Yokomizo-Nakano T, Kubota S, Sun Y, et al
    Overexpression of Hmga2 activates Igf2bp2 and remodels transcriptional program of Tet2-deficient stem cells in myeloid transformation.
    Oncogene. 2021 Jan 15. pii: 10.1038/s41388-020-01629.
    PubMed     Abstract available
    
    
    November 2020
25. SARI IN, Yang YG, Wijaya YT, Jun N, et al
    AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth.
    Oncogene. 2020 Nov 17. pii: 10.1038/s41388-020-01547.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: